Basel, Basel, Switzerland
Experienced Alliance Management professional with a multi-year track record in the biopharmaceutical industry, from biotech to global pharma. Proven ability to successfully manage a diverse portfolio of national and international (multi-program) collaborations across research, development, and commercial stage. Demonstrated expertise in complex partnering scenarios, including geographic splits and co-development / co-commercialization setting. Open-minded, collaborative, analytical, and solution-oriented team player. Known for taking both sides into account, paying attention to detail and proactive problem-solving skills. Comprehensive scientific background in antibody discovery and development, protein engineering, and with a strong understanding of technical operations, specifically in antibody manufacturing.
Management of strategic partnerships with international pharma and biotech companies for antibodies in (pre) clinical and commercial stage across various indications (e.g. oncology, immunology). This includes license and collaboration agreements for two development stage programs with two separate partners in distinct territories (Greater China and RoW) and for a commercial stage program with focus on alliance aspects for technical operations (CMC and Supply Chain). Supporting the MorphoSys-Novartis integration process including the transition of the MorphoSys Alliance Management portfolio.
Effective management of various existing and novel biopharmaceutical alliances for therapeutic antibody projects, spanning both research and clinical stages. Additionally, management of various in-licensing and out-licensing (technology) agreements. Contract and partner management (governance) within the technical operations field, including supply agreements with international CMOs and cell-line licenses.
Assignment to Alliance Management function for a multi-project antibody development collaboration with an international Germany- based pharma partner, and for the management of various license agreements. Still serving as scientific expert for internal protein engineering and next generation sequencing projects.
Management of a team (three direct reports) for customer antibody / scaffold DNA libraries synthesis projects in the biopharmaceutical field.
Development of a proprietary DNA synthesis technology (Slonomics) for the commercial production of genes and tailored DNA libraries.
Research: ‚Molecular mechanisms of Chromatin dynamics‘ and ‚Epigenetic regulation of rRNA transcription‘.
Research: 'Influence of DNA Methylation on hTERT promoter activity'.